Category: Investigational drugs

Trodusquemine is an investigational drug not approved for human use by the FDA, meaning it has no standard consumer price [1.3.1]. The key question remains: how much does trodusquemine cost in the USA for research purposes?

In a phase I clinical trial for extensive-stage small cell lung cancer (ES-SCLC), 96% of patients treated with a combination including Obatoclax experienced neutropenia [1.2.1]. This article explores the full spectrum of what are the side effects of the drug Obatoclax.

In 2019, ulotaront received Breakthrough Therapy Designation from the FDA for schizophrenia, based on promising Phase 2 trial results. This investigational drug, ulotaront, is a first-in-class trace amine-associated receptor 1 (TAAR1) agonist representing a new approach to treating psychiatric conditions with a distinct safety profile.

Trodusquemine (also known as MSI-1436) can be purchased from commercial suppliers for research purposes, but it is not available for human use in the USA [1.3.1]. This investigational drug has not been approved by any regulatory agency for public sale or prescription [1.2.2].

Trodusquemine (also known as MSI-1436) is a naturally occurring aminosterol originally discovered in the dogfish shark. This article explains how trodusquemine is administered within the context of its use in clinical research, as it is not approved for public use.